S&P Conservative Allocation Ishares (AOK) 33.35

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2016 at 9:04 AM

S&P Conservative Allocation Ishares (AOK) 33.35 $AOK

Multi-Asset ETFs: The Bets of the Hour?
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 11:37AM CDT
Multi-asset ETFs may help investors who are anxious about the longevity of the recent market rally and find U.S. Treasury ETFs overvalued too.
ZROZ: 134.30 (-0.45), GYLD: 19.19 (-0.03), YLD: 40.57 (+0.19), AOK: 33.35 (-0.07), AOM: 36.01 (-0.03), EDV: 135.50 (-0.19), YYY: 19.43 (-0.07), TLT: 136.82 (-0.13), AOR: 41.04 (-0.22)

A Conservative Approach to Asset Allocation
ETFtrends.com - ETF Trends - Tue Oct 20, 7:00AM CDT
Investors looking for combined access to equities, fixed income and other asset classes via one-stop shopping have myriad options in the world of exchange traded funds. The iShares Conservative Allocation ETF (NYSEArca: AOK ) acts like a...
AOK: 33.35 (-0.07)

BUYINS.NET: MA, GVI, DBS, HAO, PGX, AOK Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 02, 7:13AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MasterCard Inc (NYSE:MA), iShares Barclays Intermediate Govt/Credit Bd Fd (NYSE:GVI), PowerShares DB Silver Fund (NYSE

BS), Habanero Resources Inc (NYSE:HAO), Powershares Etf Fund Trusts Ii (NYSE

GX), iShares S&P Conservative Allocation ETF (NYSE:AOK) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DBS: 31.00 (-0.35), GVI: 112.83 (+0.07), AOK: 33.35 (-0.07), PGX: 15.28 (+0.02), HAO: 25.13 (-0.37), MA: 101.66 (-0.46)

BUYINS.NET: PODD, SCOR, ZINC, AOA, AOK, LWC Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Aug 05, 6:32AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Insulet Corp (NASDAQ

ODD), COMSCORE, INCORPORATION (NASDAQ:SCOR), HORSEHEAD HOLDING CORPORATION (NASDAQ:ZINC), iShares S&P Aggressive Allocation ETF (NYSE:AOA), iShares S&P Conservative Allocation ETF (NYSE:AOK), Leeward Capital Corp (NYSE:LWC) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ZINC: 0.08 (-0.01), PODD: 43.93 (-1.14), AOK: 33.35 (-0.07), LWC: 42.84 (+0.04), AOA: 47.48 (-0.31), SCOR: 31.06 (-0.28)

BUYINS.NET: FXA, DBS, UDN, SHOR, RBS, AOK Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jul 08, 7:13AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of CurrencyShares Australian Dollar Trust (NYSE:FXA), PowerShares DB Silver Fund (NYSE

BS), Powershares Db Us $ Index (NYSE:UDN), Shoretel Inc (NASDAQ:SHOR), Royal Bank of Scotland Group PLC (NYSE:RBS), iShares S&P Conservative Allocation ETF (NYSE:AOK) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DBS: 31.00 (-0.35), AOK: 33.35 (-0.07), FXA: 76.21 (-0.24), RBS: 4.75 (-0.12), UDN: 22.09 (+0.01), SHOR: 8.14 (-0.05)

AOK Makes Notable Cross Below Critical Moving Average
ETFChannel.com - Wed Mar 04, 9:55AM CST
In trading on Wednesday, shares of the iShares Core Conservative Allocation ETF crossed below their 200 day moving average of $32.71, changing hands as low as $32.68 per share. iShares Core Conservative Allocation shares are currently trading down...
AOK: 33.35 (-0.07)

iShares Adds Four Allocation ETFs to Core Lineup
ETFtrends.com - ETF Trends - Mon Feb 02, 11:00AM CST
BlackRock (NYSE: BLK) said Monday that its iShares unit, the world’s largest issuer of exchange traded funds, added four ETFs to its core lineup of funds aimed at cost-conscious buy-and-hold investors. The new additions to the iShares core suite...
AOK: 33.35 (-0.07), AOM: 36.01 (-0.03), AOA: 47.48 (-0.31), AOR: 41.04 (-0.22)

BlackRock Adds Four iShares Core Allocation ETFs for Buy-and-Hold Investors
BusinessWire - Mon Feb 02, 8:01AM CST
BlackRock, Inc. (NYSE:BLK) has expanded its iShares Core exchange traded fund offering for buy-and-hold investors to include four iShares Core Allocations ETFs. Originally launched in 2008, the existing products have been modified to hold iShares Core ETFs exclusively and have been renamed: iShares Core Conservative Allocation ETF (NYSEArca:AOK), iShares Core Moderate Allocation ETF (NYSEArca:AOM), iShares Core Growth Allocation ETF (NYSEArca:AOR) and iShares Core Aggressive Allocation ETF (NYSEArca:AOA).
AOK: 33.35 (-0.07), AOM: 36.01 (-0.03), BLK: 365.65 (-8.22), AOA: 47.48 (-0.31), AOR: 41.04 (-0.22)

Inside the New Global X JPMorgan Efficiente Index ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:00AM CST
The latest Global X ETF looks to be a fund of funds across a variety of different markets.
IYLD: 25.17 (-0.13), AOK: 33.35 (-0.07), MDIV: 19.09 (+0.01), AOM: 36.01 (-0.03), EFFE: 24.76 (+0.43)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...